From Lab to Application: Quantum X Labs' Path Toward Viewbix Ownership

Rhea-AI Summary

Viewbix (Nasdaq: VBIX) completed a definitive share purchase agreement dated December 15, 2025 to acquire 100% of Quantum X Labs' fully diluted share capital, issuing common stock and pre-funded warrants equal to ~40% of its capital at closing (inclusive of 800,00 shares in a related private placement).

Additional contingent consideration of up to ~12.7 million shares or pre-funded warrants is payable upon achievement of post-closing technological and commercial milestones, while Quantum X Labs' quantum IP and prototypes move toward commercialization under Viewbix ownership.

Positive

• 100% acquisition of Quantum X Labs' fully diluted share capital
• ~40% of Viewbix equity issued at closing to acquire the lab
• Access to public-company capital and strategic resources to scale quantum technologies
• Contingent milestones link additional consideration to technological/commercial progress

Negative

• Significant immediate dilution: ~40% issued at closing
• Potential further dilution from up to ~12.7 million contingent shares/warrants
• Paid promotional disclosure creates a conflict of interest risk for investor messaging

News Market Reaction – VBIX

+4.65%

1 alert

+4.65% News Effect

On the day this news was published, VBIX gained 4.65%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Acquisition equity stake: 40% of capital Additional earn-out securities: Up to ~12.7M shares/warrants Approved share issuance: 20,488,442 shares +5 more

8 metrics

Acquisition equity stake 40% of capital VBIX stock and pre-funded warrants issued as of Dec 15, 2025

Additional earn-out securities Up to ~12.7M shares/warrants Contingent on post-closing milestones for Quantum X Labs

Approved share issuance 20,488,442 shares Shares tied to PIPE, warrants, and Quantum X Labs acquisition (DEF 14C)

PIPE gross proceeds $1.4 million Financing supporting VBIX and Quantum transaction (DEF 14C)

Net loss $16.3 million Six months ended June 30, 2025 (10-Q)

Prior-year net loss $9.4 million Six months ended June 30, 2024 (10-Q comparison)

Cash and cash equivalents $1.99 million As of June 30, 2025 (10-Q)

Bank loans $5.39 million As of June 30, 2025 (10-Q)

Market Reality Check

Price: $1.80 Vol: Volume 23,102 is 1.88x th...

high vol

$1.80 Last Close

Volume Volume 23,102 is 1.88x the 20-day average of 12,290, showing elevated interest pre-news. high

Technical Shares at $1.72 are trading below the 200-day MA $3.13, despite today’s gain of 6.17%.

Peers on Argus

VBIX gained 6.17% with higher volume, while sector peers were mixed: SCOR up 0.1...

2 Up 1 Down

VBIX gained 6.17% with higher volume, while sector peers were mixed: SCOR up 0.15%, SJ down 2.98%, GIFT down 1.89%, FENG flat, ZDGE up 6.13%. Momentum scanner peers (GITS, ZDGE, BODI) also showed both up and down moves, indicating stock-specific drivers rather than a broad sector rotation.

Historical Context

5 past events · Latest: Feb 24 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 24	Quantum milestone update	Positive	+2.4%	Quantum Transportation milestone and IP license supporting quantum decoder deployment.
Feb 23	Acquisition terms detail	Positive	-1.8%	Definitive agreement to acquire 85–100% of Quantum X Labs and amended placement.
Jan 29	Acquisition highlight	Positive	+0.5%	Planned Quantum X Labs acquisition and Quantum Gyro performance improvements.
Jan 27	Atomic clock progress	Positive	-0.5%	Quantum Accuracy atomic clock lab results and deal timeline reiteration.
Jan 21	Error correction milestone	Positive	+0.0%	Quantum Transportation QEC Milestone 1 and acquisition closing expectations.

Pattern Detected

Recent quantum-related announcements have usually led to modest, sometimes negative, next-day moves, suggesting mixed market confidence despite generally positive strategic news.

Recent Company History

Over the last few months, VBIX has issued a series of updates around its Quantum X Labs acquisition and related portfolio companies. News on quantum error correction, atomic clocks, navigation, and implementation milestones generally read as positive, but price reactions were modest, with several instances of small declines. Today’s article fits this ongoing shift from ad-tech roots toward quantum technology, now framed as a completed ownership transition and broader strategic repositioning.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-05

VBIX has an active S-3 shelf registration filed on 2025-08-05 that is not yet effective and shows no recorded usage in recent 424B filings. This provides a framework for potential future capital raising once effective but does not itself indicate any executed issuance.

Market Pulse Summary

This announcement highlights VBIX’s transition from ad-tech roots toward full ownership of Quantum X...

Analysis

This announcement highlights VBIX’s transition from ad-tech roots toward full ownership of Quantum X Labs, outlining a structure where Quantum’s sellers received about 40% of VBIX’s capital plus potential earn-out securities tied to milestones. Regulatory filings also show approvals for up to 20,488,442 new shares and a net loss of $16.3M with cash of $1.99M. Investors may watch for progress on quantum applications, capital-raising steps under the S-3, and dilution from milestone issuances.

Key Terms

pre-funded warrants, private placement, letter of intent, definitive share purchase agreement, +4 more

8 terms

pre-funded warrants financial

"Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

private placement financial

"inclusive of 800,00 shares of its common stock issued in a related private placement"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

letter of intent regulatory

"strategic acquisition—initially announced via a letter of intent and formalized in a definitive"

A letter of intent is a document that shows an agreement in principle between parties to work towards a future deal or transaction. It outlines their intentions and key terms, acting like a roadmap before a formal contract is signed. For investors, it signals serious interest and helps clarify expectations early in the process.

definitive share purchase agreement regulatory

"formalized in a definitive share purchase agreement on December 15, 2025—Quantum X Labs"

A definitive Share Purchase Agreement is a final, official document that confirms the details of a sale where one person or company agrees to buy shares from another. It matters because it legally locks in the agreed terms, making sure both sides understand and follow through with the deal. Think of it as the final contract that makes the purchase official.

paid promotional communication financial

"This press release constitutes a paid promotional communication. Viewbix has engaged"

Paid promotional communication is any message—articles, alerts, emails, social posts, or ads—that a company, investor, or other party pays to publish to promote a stock or investment. Investors should treat it like a paid billboard or infomercial: the goal is persuasion rather than independent reporting, so knowing content was paid for helps assess bias, detect conflicts of interest, and judge how much weight to give the claims when valuing a security.

forward-looking statements regulatory

"Forward-looking statements referenced in this article are subject to risks and uncertainties"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

clinical trials medical

"quantum-enhanced methods for clinical trials and data analysis, demonstrating the lab's"

Clinical trials are carefully controlled studies that test whether a new drug, device or treatment is safe and effective in people, moving through successive stages that increase the number of participants and the rigor of testing. Investors care because trial outcomes determine whether a product can be approved and sold, shaping a company’s future revenue, valuation and risk profile—think of it as proof-of-concept testing that decides if a prototype becomes a market-ready product.

monte carlo sampling technical

"provisional patent for generating Quantum Markov Chain Monte Carlo sampling points"

A statistical technique that runs thousands of random simulations to estimate the range of possible outcomes for an investment or financial plan. Think of it like rolling dice many times to see how often different results occur; it helps investors gauge the likelihood of gains, losses, or breaching a target under varying assumptions and uncertainties, so they can make better decisions about risk, diversification, and capital allocation.

AI-generated analysis. Not financial advice.

Moonage Media examines the growth trajectory of Quantum X Labs in connection with Viewbix's pending acquisition

HONG KONG, March 2, 2026 /PRNewswire/ -- Quantum X Labs Ltd., an innovative Israeli quantum technology hub, is on the cusp of a transition from a research-focused laboratory to a player in quantum applications. Through Viewbix Inc.'s (Nasdaq: VBIX) strategic acquisition—initially announced via a letter of intent and formalized in a definitive share purchase agreement on December 15, 2025—Quantum X Labs is poised to accelerate its path from breakthrough innovations to real-world market impact. This brings cutting-edge quantum technologies to a public company.

The Acquisition Framework: A Milestone-Driven Path Forward

Viewbix acquired 100% of Quantum X Labs' fully diluted share capital. At closing, Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital as of December 15, 2025 (inclusive of 800,00 shares of its common stock issued in a related private placement). Additional consideration—potentially up to around 12.7 million shares or pre-funded warrants—is subject to the achievement of certain post-closing milestones tied to technological and commercial achievements.

Following the closing, Quantum X Labs operates under Viewbix's, gaining access to additional capital and broader strategic resources to scale its operations.

Core Technologies: From Quantum Research to Disruptive Applications

Quantum X Labs serves as a multi-disciplinary hub for quantum advancements, with a growing patent portfolio that includes:

• Quantum-Enhanced Navigation via Quantum Gyro: A standout portfolio company, Quantum Gyro Ltd., has achieved breakthrough results in quantum-based gyroscope chip technology. Recent developments demonstrate performance improvements of several orders of magnitude over traditional and current gyroscope systems. This enables "unjammable, self-contained navigation" that operates independently of GPS or satellite signals—potentially for days, weeks, or longer without external corrections. Such capability addresses critical needs in defense, aerospace, autonomous vehicles, underwater operations, and space missions, where GPS denial or jamming poses major risks. .
• Atomic Clocks and Precision Timing: Quantum X Labs is advancing next-generation atomic clock technologies through subsidiaries like Quantum Accuracy, promising ultra-precise timing for applications in telecommunications, financial systems, and scientific instrumentation.
• Quantum Algorithms and Error Correction: The portfolio features innovative IP in quantum error correction (including AI-enhanced methods) and quantum-accelerated sampling techniques, such as a provisional patent for generating Quantum Markov Chain Monte Carlo sampling points. These advancements improve quantum computing reliability and extend to specialized uses like enhanced clinical trial analytics and personalized medicine.
• Emerging Applications: Recent filings highlight quantum-enhanced methods for clinical trials and data analysis, demonstrating the lab's versatility in applying quantum principles across industries.

Under Viewbix's ownership, these lab-stage innovations gain the infrastructure to move forward through potential partnerships, prototype scaling, regulatory pathways, and trials strategies that a standalone startup might struggle to fund or execute.

Why This Matters for Viewbix

This acquisition represents an expansion of Viewbix's existing business units toward potentially high-growth quantum sectors, diversifying beyond Viewbix's core ad-tech roots into transformative fields with massive upside. Quantum technologies are attracting intense global interest, driven by defense needs, AI synergies, and commercialization momentum. By bringing Quantum X Labs to market under its ownership, Viewbix aims to position itself at the forefront of this emerging quantum industry—potentially driving long-term shareholder value through innovation and enhanced market positioning.

Paid Promotional Disclosure

This press release constitutes a paid promotional communication. Viewbix has engaged a third-party service provider to provide investor awareness and promotional services, including the dissemination of this press release, and has paid a fee for such services. Viewbix exercises editorial control over the content of this press release but does not control how, when, or to whom the information is distributed by such third party.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of Viewbix. Investing in Viewbix's securities involves significant risks, and readers are encouraged to review Viewbix's filings with the U.S. Securities and Exchange Commission available at www.sec.gov before making any investment decision.

Moonage Media Disclaimer

This article was produced by Moonage Media, a brand / division of MR Solutions Limited (Hong Kong), and is provided for general informational and promotional purposes only. The content does not constitute investment advice, financial advice, medical advice, or a recommendation to buy, sell, or hold any securities, nor does it constitute an offer or solicitation in any jurisdiction.

Moonage Media is not a registered broker-dealer, investment adviser, securities analyst, or medical professional. The information presented is based on publicly available sources and statements believed to be reliable at the time of publication; however, Moonage Media makes no representations or warranties as to the accuracy or completeness of the information and has not independently verified all data referenced.

Certain content published by Moonage Media may be sponsored or compensated by the company discussed or its affiliates, which may create a potential conflict of interest. Readers are encouraged to conduct their own independent research and consult qualified financial, legal, medical, or other professional advisers before making any investment or health-related decisions.

Forward-looking statements referenced in this article are subject to risks and uncertainties, and actual results may differ materially. Past performance is not indicative of future results.

For full disclosures, risk factors, and forward-looking statements, please visit:
https://moonage.media/disclaimer/

Contact:
Moonage Media
office@moonage.media 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, forward-looking statements in this press release include the achievement of certain post-closing milestones tied to technological and commercial achievement, the expected growth of the quantum navigation/compass market, how under Viewbix's ownership, Quantum X Labs' lab-stage innovations gain the infrastructure to move forward through potential partnerships, prototype scaling, regulatory pathways, and trials strategies that a standalone startup might struggle to fund or execute, how the acquisition represents an expansion of Viewbix's existing business units toward potentially high-growth quantum sectors, diversifying beyond Viewbix's core ad-tech roots into transformative fields with massive upside and how Viewbix aims to position itself at the forefront of this emerging quantum industry—potentially driving long-term shareholder value through innovation and enhanced market positioning. Because such statements deal with future events and are based on Viewbix's current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.

View original content:https://www.prnewswire.com/news-releases/from-lab-to-application-quantum-x-labs-path-toward-viewbix-ownership-302701217.html

SOURCE Moonage Media

FAQ

What did Viewbix (VBIX) acquire from Quantum X Labs on December 15, 2025?

Viewbix acquired 100% of Quantum X Labs' fully diluted share capital in a definitive agreement. According to the company, closing consideration included common stock and pre-funded warrants representing about 40% of Viewbix capital as of December 15, 2025.

How much equity did Viewbix (VBIX) issue at closing to buy Quantum X Labs?

Viewbix issued common stock and pre-funded warrants equal to roughly 40% of its capital at closing. According to the company, that figure is inclusive of a related private placement of 800,00 shares.

Is there additional payment due to Quantum X Labs after the Viewbix acquisition?

Yes, Viewbix may pay contingent consideration tied to milestones, up to about 12.7 million shares or pre-funded warrants. According to the company, these are payable upon specified technological and commercial achievements.

What quantum technologies did Quantum X Labs bring to Viewbix (VBIX)?

Quantum X Labs contributes IP in quantum gyroscopes, atomic clocks, and quantum error correction methods. According to the company, these include a quantum gyro chip and provisional patents for advanced sampling and error-correction techniques.

What should investors consider about the paid promotional disclosure in the Viewbix (VBIX) release?

The release is a paid promotional communication and may reflect a promotional bias. According to the company, a third party was paid for investor awareness services, and viewers should review SEC filings before investing.